FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer By Ogkologos - January 17, 2025 873 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ADRIATIC study Source RELATED ARTICLESMORE FROM AUTHOR Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma ESMO Welcomes the European Parliament’s (EP) Call for a Sustainable Cancer Workforce to Deliver Quality Care for Patients with Cancer ESMO Welcomes the Inclusion of Tobacco Provisions in European Parliament’s Report on Cardiovascular Diseases and Calls for Additional Measures to Prevent Cancer MOST POPULAR What to Expect During a Skin Cancer Screening May 31, 2022 FDA Approves Zolbetuximab-clzb with Chemotherapy for Gastric or Gastro-Oesophageal Junction Adenocarcinoma November 13, 2024 Happy Occupational Therapy Month April 19, 2023 Mom Discovers She Has Breast Cancer After Weaning Twin Boys, Says... November 20, 2019 Load more HOT NEWS The HPV Vaccine: Increasing the Use of an Important Cancer Prevention... Study Clarifies Timing of Immunotherapy for Advanced Bladder Cancer Surgery for Recurrent Ovarian Cancer Does Not Improve Survival Blind Man Overcomes Life Of Struggles & Becomes An Incredible Woodworker
